Effects of Whole Body Hyperthermia (41.8°C) on the Frequency of Tumor Cells in the Peripheral Blood of Patients with Advanced Malignancies
暂无分享,去创建一个
D. Atanackovic | K. Pantel | D. Hossfeld | M. Otte | A. Nierhaus | S. Hegewisch‐Becker | Katharina Braun | A. Corovic
[1] J. Haveman,et al. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells , 2005, Journal of Cancer Research and Clinical Oncology.
[2] N. Hornback,et al. Whole-body hyperthermia decreases lung metastases in lung tumor-bearing mice, possibly via a mechanism involving natural killer cells , 1987, Journal of Clinical Immunology.
[3] D. Atanackovic,et al. 41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases , 2002, Cancer Immunology, Immunotherapy.
[4] D. Atanackovic,et al. Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] P. Wust,et al. Hyperthermia in combined treatment of cancer. , 2002, The Lancet Oncology.
[6] E. Repasky,et al. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[7] D. Jäger,et al. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer. , 2001, European Journal of Cancer.
[8] M. Speicher,et al. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. , 2000, Cancer research.
[9] S. Schwartz,et al. Prostate cancer and other xenografts from cells in peripheral blood of patients. , 2000, Cancer research.
[10] T. Dimpfl,et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.
[11] D. Weaver,et al. Breast Cancer Cells in the Blood: A Pilot Study , 1999, The breast journal.
[12] J. Rosai,et al. Molecular detection of micrometastases and circulating tumor cells in solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] R. Cote,et al. Detection and clinical importance of micrometastatic disease. , 1999, Journal of the National Cancer Institute.
[14] M. Speicher,et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Hartmann,et al. Multiple mutation analyses in single tumor cells with improved whole genome amplification. , 1999, The American journal of pathology.
[16] J. Nesland,et al. Increased sensitivity for detection of micrometastases in bone‐marrow/peripheral‐blood stem‐cell products from breast‐cancer patients by negative immunomagnetic separation , 1998, International journal of cancer.
[17] M. Caligiuri,et al. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever‐like) whole body hyperthermia , 1998, Journal of cellular physiology.
[18] A. van Dalen,et al. Epitope Specificity of 30 Monoclonal Antibodies against Cytokeratin Antigens: The ISOBM TD5-1 Workshop , 1998, Tumor Biology.
[19] M. Caligiuri,et al. TUMOR CELL APOPTOSIS, NK CELL RECRUITMENT AND TUMOR VASCULAR CHANGES ARE INDUCED BY LOW TEMPERATURE, LONG DURATION WHOLE BODY HYPERTHERMIA , 1997 .
[20] H. Kampinga,et al. Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells. , 1997, British Journal of Cancer.
[21] G. Wilding,et al. Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] G. Assmann,et al. Isolation of prostate-derived single cells and cell clusters from human peripheral blood. , 1996, Cancer research.
[23] K. Pantel,et al. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Mentzel,et al. Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma. , 1996, European journal of cancer.
[25] G. Schlimok,et al. Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. , 1996, Cancer genetics and cytogenetics.
[26] B. Dréno,et al. Circulating micrometastases following oncological surgery , 1996, The Lancet.
[27] K. Pantel,et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases , 1996, The Lancet.
[28] S. Loric,et al. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy , 1995, The Lancet.
[29] Gabriele Multhoff,et al. A stress‐inducible 72‐kDa heat‐shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells , 1995, International journal of cancer.
[30] R. Knuechel,et al. Tumor cells in blood shed from the surgical field. , 1995, Archives of surgery.
[31] M. Mentzel,et al. Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. , 1994, Cancer research.
[32] J. Cohen,et al. A new technological approach to radiant heat whole body hyperthermia. , 1994, Cancer letters.
[33] L. Kanz,et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments] , 1994 .
[34] L. Kanz,et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. , 1994, Blood.
[35] G. Kocjan,et al. Detection and enumeration of circulating tumour cells in colorectal cancer , 1993, The British journal of surgery.
[36] G. Schlimok,et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients , 1992, The Lancet.
[37] M. Gautherie,et al. Whole Body Hyperthermia: Biological and Clinical Aspects , 1992, Clinical Thermology.
[38] F M Waterman,et al. Blood flow in human tumors during local hyperthermia. , 1991, International journal of radiation oncology, biology, physics.
[39] A. Milligan,et al. Effect of hyperthermia on normal tissue toxicity and on adriamycin pharmacokinetics in dogs. , 1991, Cancer research.
[40] A. Neville,et al. A Nontoxic System for 41.8°C Whole-Body Hyperthermia: Results of a Phase I Study Using a Radiant Heat Device , 1985 .
[41] M. Maeta,et al. Effects of total-body hyperthermia on metastases from experimental mouse tumors. , 1985, Cancer research.
[42] H. Suit,et al. Effect of whole-body hyperthermia on cell survival, metastasis frequency, and host immunity in moderately and weakly immunogenic murine tumors. , 1983, Cancer research.
[43] Benjamin Geiger,et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.
[44] D. Kapp,et al. Increased skeletal metastases of spontaneous canine osteosarcoma after fractionated systemic hyperthermia and local X-irradiation. , 1981, Cancer research.
[45] B. Barlogie,et al. Total-body hyperthermia with and without chemotherapy for advanced human neoplasms. , 1979, Cancer research.
[46] D. Lees,et al. A phase-I trial of systemic heat and adriamycin (A) , 1979 .
[47] J. Dickson,et al. Effect of hyperthermia on the immunocompetence of VX2 tumor-bearing rabbits. , 1978, Cancer research.
[48] A. Yerushalmi. Influence on metastatic spread of whole-body or local tumor hyperthermia. , 1976, European journal of cancer.
[49] J. Dickson,et al. Stimulation of tumour cell dissemination by raised temperature (42°C) in rats with transplanted Yoshida tumours , 1974, Nature.
[50] J. Dickson,et al. Total-body hyperthermia versus primary tumor hyperthermia in the treatment of the rabbit VX-2 carcinoma. , 1972, Cancer research.